Prof. Dr. med. Christoph Kleinschnitz

Christoph Kleinschnitz, born in 1973, is an experimental neuroscientist and clinical consultant of neurology. He studied human medicine at the Julius Maximilians University in Würzburg, Germany where he received his MD title in 2001. He finished his training as a neurologist in 2007. In 2011 he was appointed Full Professor of Neurology and Stroke Medicine at the University of Würzburg, Germany. He now works as an attending physician ("Geschäfsführender Oberarzt") in the Department of Neurology, University Hospital Würzburg where he runs the Stroke Unit. As a complementary focus aside his clinical activity, he deals with innovative translational approaches in stroke therapy. Here, Dr. Kleinschnitz has particularly investigated the role of platelets and plasmatic coagulation in thrombus formation and stroke development. Other scientific fields of interests comprise the blood-brain-barrier and molecular mechanisms of brain edema formation as well as the role of inflammatory processes and free radicals in stroke pathophysiology. Dr. Kleinschnitz serves as an editor for PLoS One and Stroke and together with Wolf-Rüdiger Schäbitz, Germany has founded the first Open Access journal in the field of translational stroke research, Experimental & Translational Stroke Medicine (www.etsmjournal.com). In 2008 he was awarded "Germany's Young Scientist of the Year" and in 2011 he received the Heinrich-Pette-Award from the German Neurological Society.





Prof. Dr. med. Ralf Linker

Ralf Linker studied human medicine in Freiburg/Breisgau, Berlin and St. Louis, Missouri. After a molecular-biological doctoral thesis at the Institute of Biochemistry, University of Freiburg, he worked as resident physician at the University of Würzburg, Department of Neurology (Prof Toyka) as well as in Göttingen (Prof Bähr) and at the Ruhr-University of Bochum, Department of Psychiatry (Prof Juckel). From 2007 to 2010 he worked as senior physician at the St. Josef Hospital, Ruhr University in Bochum (Director: Prof Gold), where he was head of the neurological research laboratory. Since September 2010, he is head of the Neuroimmunology Section and Attending Physican at the Department of Neurology, University Hospital Erlangen. His interests focus on multiple sclerosis and neurodegenerative diseases, particularly in the field of experimental models. The emphasis is on examining mechanisms of neurodegeneration and neuroprotection as well as research on mechanisms of action of established immune therapies and novel ways of treatment in the translational approach. In 2002, Ralf Linker was awarded the Sobek-Stiftung young researchers' prize as well as in 2005, the Helmut-Bauer young researchers' prize for MS research.





Prof. Dr. med. Dr. rer. nat. Sven G. Meuth

Sven Meuth studied human medicine and neurobiology at the Otto-von-Guericke University in Magdeburg, Germany and received his PhD titles in 2005 (Dr. med.) and 2007 (Dr. rer. nat.) at the associated Institute of Physiology. In 2004 he switched to the Neurological University Würzburg, where he started his neurology education under the supervision of Prof. K. Toyka. Since 2010 he is appointed as full professor at the Clinic of Neurology (inflammatory disorders of the nervous system and neuroonkology; Prof. Wiendl) and in parallel affiliated to the Institute of Physiology (neuropathophysiology; Prof. Pape) in Münster. His scientific interests comprise the investigation of autoimmune inflammation and neurodegeneration (focus: ion channels) in animal models of multiple sclerosis. For his scientific work on the functional expression of ion channels on T cells, he received the Helmut-Bauer-Award from the University of Göttingen (2009) and the Sobek-Young-Investigator-Award (2010).
Prof. Dr. med. Thomas Korn

Thomas Korn studied medicine in Würzburg and London and received his MD from Würzburg University Medical School in 2000. After recidencies in clinical neurology at the Universities of Würzburg (Prof. Toyka) and Homburg/Saar (Prof. Becker, Prof. Jung), he obtained board approval in neurology (Facharzt) in 2005. From 2005 to 2008, he focused on T cell immunology during a postdoctoral fellowship at Harvard Medical School, Boston (Prof. Kuchroo). After returning to Germany, he works now as an attending physician in the Department of Neurology at the Technical University Munich and holds the position of an associate professor for experimental neuroimmunology with a strong focus on T cell associated cytokine networks in CNS autoimmunity. For his scientific work on T cell development and regulation, he received the Helmut-Bauer-Award from the University of Göttingen (2007), the Sobek-Young-Investigator-Award (2008), a Heisenberg-Award from the German Research Council (2008), and the Pette-Award from the German Neurological Society (2010).











Prof. Dr. med. Tim Magnus

Tim Magnus studied medicine in Hamburg and Chicago and received his MD from Hamburg University Medical School in 1998. Starting his internship and junior residency in clinical neurology at the University of Würzburg (Prof. Toyka), he switched to the medical University Homburg/Saar (Prof. Becker, Prof. Jung) in 2001, where he obtained board approval for specialising in neurology (Facharzt) in 2004. From 2004 to 2007, he undertook a postdoc fellowship at the National Institute of Aging, Baltimore (Prof. Rao, Prof. Mattson), where he worked on glial precursor biology and eventually on the immunology of stroke. After returning to Germany in 2007, he works now as an attending physician in the Department of Neurology at the Hamburg University, where he runs his own lab which focuses on stroke research. Their main interest is the immunology of stroke and the translation to the human situation. For his scientific work he was awarded the Langheinrich Preis.
Christoph Kleinschnitz

Thomas Korn

Ralf Linker

Tim Magnus

Sven G. Meuth